FGF1 and type 1 diabetes mellitus: Similar to the effect of leptin, we hypothesized that ICV administration of FGF1 or FGF19 in a streptozotocin-induced rat model of T1D might lower plasma glucose concentrations and normalize rates of hepatic glucose production by suppressing lipolysis through reductions in activation of the HPA axis.